Mycophenolic Acid Structural Formula. (Myfortic 01)
Myfortic Tablet, Delayed Release
Product Images NDC 0078-0385
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Myfortic (NDC 0078-0385). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Novartis Pharmaceuticals Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Principal Display Panelpackage Label – 180 mgrx Only Ndc 0078-0385-66 (Myfortic 02)
Myfortic® is a brand of delayed-release tablets containing mycophenolic acid to help prevent rejection of organ transplants. Each package contains 120 tablets with a strength of 180mg per tablet, and is dispensed with a medication guide for patients. The manufacturer is Novartis.*
Principal Display Panelpackage Label – 360 mgrx Only Ndc 0078-0386-66 (Myfortic 03)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
